돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 659751생성일: 2026년 10월 23일

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/ko/reaction/659751

반응식

참여 물질

역할이름HCID투입량
반응물Piperazine DihydrochlorideHCID 8893—
반응물Sodium HydroxideHCID 14798—
반응물Sodium AzideHCID 33557—
반응물4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
용매WaterHCID 962—
용매DimethylformamideHCID 6228—
생성물IrbesartanHCID 374998%

반응 단계

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in N,N-dimethylformamide (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and 20 ml water was added. The reaction mixture was adjusted to pH of about 12 using 10% NaOH solution. The alkaline solution was washed with toluene (15 ml) and the aqueous phase was neutralized to pH of 6.5 using concentrated HCl. The resulting suspension was stirred for 3 hours at room temperature and filtered to obtain irbesartan (5.8 g, 98% purity by HPLC). Recrystallization of the Product using ethanol results in 5.2 g of irbesartan with 99.94% purity and content of the impurity 2-n-butyl-3-[(2′-carboxamidobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one: 0.07%.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08080670B2
출처 데이터셋uspto-grants-2011_12
ORD IDord-a87991bb691b4f3d9269906fa7cf021a
출처 메모uspto-grants-2011_12